Kiniksa Pharmaceuticals International (KNSA) Return on Capital Employed [ROCE] (2018 - 2026)
Kiniksa Pharmaceuticals International's Return on Capital Employed [ROCE] was 14.54% in Q2 2026, up 13.67 percentage points from 0.87% a year earlier but down 0.07 percentage points from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Kiniksa Pharmaceuticals International came in at 14.49%, up 24.56 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +72.74 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -10.07% in FY2024 (-4.21 pp), -5.87% in FY2023 (-9.14 pp), 3.27% in FY2022 (+66.86 pp) and -63.59% in FY2021 (-5.34 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -79.11% (Q4 2021) and 14.61% (Q1 2026) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for six straight quarters, with an average year-over-year change of +8.98 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2022 (a gain of 81.47 percentage points); the worst was Q4 2021 (a drop of 32.15 percentage points).
- Per Business Quant data, KNSA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 14.61% (Q1 2026), 12.90% (Q4 2025) and 6.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 14.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.54% |
| Mar 31, 2026 | 14.61% |
| Dec 31, 2025 | 12.90% |
| Sep 30, 2025 | 6.78% |
| Jun 30, 2025 | 0.87% |
| Mar 31, 2025 | -3.21% |
| Dec 31, 2024 | -9.76% |
| Sep 30, 2024 | -5.79% |
| Jun 30, 2024 | -6.16% |
| Mar 31, 2024 | -6.66% |
| Dec 31, 2023 | -5.71% |
| Sep 30, 2023 | -4.47% |
| Jun 30, 2023 | 9.16% |
| Mar 31, 2023 | 5.28% |
| Dec 31, 2022 | 2.37% |
| Sep 30, 2022 | -11.62% |
| Jun 30, 2022 | -61.78% |
| Mar 31, 2022 | -71.98% |
| Dec 31, 2021 | -79.11% |
| Sep 30, 2021 | -74.87% |
API Access
Kiniksa Pharmaceuticals International Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();